Swedencare AB (publ) (SECARE.ST)
SEK 48.8
(-2.4%)
SEK 48.8
(-2.4%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.37 SEK | -39.34% |
| 2022 | 0.61 SEK | 24.49% |
| 2021 | 0.49 SEK | -12.5% |
| 2020 | 0.56 SEK | 47.37% |
| 2019 | 0.38 SEK | 26.67% |
| 2018 | 0.30 SEK | 36.36% |
| 2017 | 0.22 SEK | 57.14% |
| 2016 | 0.14 SEK | 16.67% |
| 2015 | 0.12 SEK | 162.58% |
| 2014 | 0.05 SEK | 4470.0% |
| 2013 | 0.00 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.13 SEK | -31.58% |
| 2024 Q1 | 0.19 SEK | 331.99% |
| 2024 Q3 | 0.15 SEK | 15.38% |
| 2023 Q1 | 0.11 SEK | 152.38% |
| 2023 FY | - SEK | -39.34% |
| 2023 Q2 | 0.10 SEK | -9.09% |
| 2023 Q3 | 0.24 SEK | 140.0% |
| 2023 Q4 | -0.08 SEK | -134.12% |
| 2022 Q1 | 0.08 SEK | 123.85% |
| 2022 FY | - SEK | 24.49% |
| 2022 Q3 | 0.15 SEK | -69.39% |
| 2022 Q4 | -0.21 SEK | -240.0% |
| 2022 Q2 | 0.49 SEK | 522.62% |
| 2021 Q2 | 0.14 SEK | 75.0% |
| 2021 Q3 | 0.02 SEK | -87.14% |
| 2021 Q4 | -0.33 SEK | -1933.33% |
| 2021 Q1 | 0.08 SEK | -65.22% |
| 2021 FY | - SEK | -12.5% |
| 2020 Q3 | 0.03 SEK | -43.33% |
| 2020 Q2 | 0.06 SEK | -45.45% |
| 2020 FY | - SEK | 47.37% |
| 2020 Q4 | 0.23 SEK | 576.47% |
| 2020 Q1 | 0.11 SEK | 51.52% |
| 2019 Q3 | 0.11 SEK | 27.91% |
| 2019 Q2 | 0.09 SEK | -21.82% |
| 2019 Q1 | 0.11 SEK | 51.1% |
| 2019 FY | - SEK | 26.67% |
| 2019 Q4 | 0.07 SEK | -34.0% |
| 2018 Q1 | 0.06 SEK | 23.46% |
| 2018 Q3 | 0.09 SEK | 18.92% |
| 2018 Q4 | 0.07 SEK | -17.27% |
| 2018 FY | - SEK | 36.36% |
| 2018 Q2 | 0.07 SEK | 23.33% |
| 2017 Q3 | 0.06 SEK | 100.0% |
| 2017 Q4 | 0.05 SEK | -13.21% |
| 2017 FY | - SEK | 57.14% |
| 2017 Q1 | 0.07 SEK | 725.0% |
| 2017 Q2 | 0.03 SEK | -57.58% |
| 2016 Q1 | 0.06 SEK | 41.18% |
| 2016 Q4 | 0.01 SEK | -80.95% |
| 2016 Q3 | 0.04 SEK | 23.53% |
| 2016 Q2 | 0.03 SEK | -43.33% |
| 2016 FY | - SEK | 16.67% |
| 2015 Q1 | 0.02 SEK | 0.0% |
| 2015 FY | - SEK | 162.58% |
| 2015 Q4 | 0.04 SEK | 0.24% |
| 2015 Q2 | 0.05 SEK | 120.94% |
| 2015 Q3 | 0.04 SEK | -17.99% |
| 2014 FY | - SEK | 4470.0% |
| 2013 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AcuCort AB | -0.16 SEK | 331.25% |
| AlzeCure Pharma AB (publ) | -0.60 SEK | 161.667% |
| BioGaia AB (publ) | 3.62 SEK | 89.779% |
| Enzymatica AB (publ) | -0.28 SEK | 232.143% |
| Enorama Pharma AB (publ) | -1.61 SEK | 122.981% |
| Gabather AB (publ) | -0.65 SEK | 156.923% |
| Klaria Pharma Holding AB (publ.) | -0.36 SEK | 202.778% |
| Moberg Pharma AB (publ) | -1.33 SEK | 127.82% |
| Nanexa AB (publ) | -1.09 SEK | 133.945% |
| Newbury Pharmaceuticals AB (publ) | -0.72 SEK | 151.389% |
| ODI Pharma AB | 0.02 SEK | -1481.197% |
| Orexo AB (publ) | -3.73 SEK | 109.92% |
| Probi AB (publ) | 1.48 SEK | 75.0% |
| Swedish Orphan Biovitrum AB (publ) | 7.47 SEK | 95.047% |
| Toleranzia AB | -0.06 SEK | 760.714% |
| Vivesto AB | -0.74 SEK | 150.0% |